Announcement

Collapse
No announcement yet.

New soon available drug - SF 102

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • New soon available drug - SF 102

    I encountered some interesting information about new drug targeting dry eye: SF 102.

    On manufacturer page: http://www.sifi.it/english/imghome/pipeline-en.jpg you can see it's now within approval state.
    On this page: http://www.evaluategroup.com/Universal/View.aspx?type=Report&id={23D6C352-1933-41D7-A788-054D46E19AAA}&params=%3CPARAMS%20currencyId=%220%2 2%3E%3CPARAM%20linkKind=%221%22%20compId=%221019%2 2%20name=%22eye%20+disorders%22%20itemId=%2248b%22 %20/%3E%3C/PARAMS%3E
    there's stated that approval and European launch should happend on (maybe to) 31.12.2013 (maybe it's already approved as some other columns there indicate).
    I could not find any useful information about this drug, but every quarter new dry eye pipeline review (paid, free is only content) mentions it.

    If someone knows more about this drug (mechanism, ...), please share this info here.

  • #2
    I forgot to mention that the company Sifi (Italian company) is sponsor of Tear Film & Ocular Surface Society.

    Comment


    • #3
      Some more information on upcoming treatments here as well:

      http://www.prlog.org/11340835-dry-ey...s-to-2017.html

      Comment


      • #4
        some upcoming drugs are also in that second link, but it seems to be not working. Just put into google: 'SF102 site:evaluategroup.com' and one link shows a huge list of many drugs, both released and not yet released. There are also some terms, like when it should be approved.
        Lifitigrast should be approved by 31.12.2015 according to their page, Cyclokat should be approved by 31.12.2014 in Europe, ....

        Comment


        • #5
          Some more information on one of the drugs mentioned, Remura:

          http://www.prnewswire.com/news-relea...103037129.html

          Comment


          • #6
            Any new about this new drug?

            Comment

            Working...
            X